Arimidex 1mg Tablet
Arimidex 1mg Tablet
| Therapeutic Class | : Nonsteroidal aromatase inhibitors |
| Manufacturer | : AstraZeneca |
| Country of origin | : UK |
| Packaging | : 2 x 14 Tablets |
| Dosage | : As directed by physician |
| Chemical composition | : Anastrozole 1mg |
| Indications | : Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Treatment of advanced breast cancer in post-menopausal women for which “Arimidex” has efficacy at least as good as tamoxifen. Use in Oestrogen receptor negative patients is not recommended. Adjuvant treatment of early breast cancer in hormone receptor positive post-menopausal woman who have received 2 to 3 years of adjuvant tamoxifen. |
